550 related articles for article (PubMed ID: 32029454)
41. Role of APD-Ribosylation in Bone Health and Disease.
Wang C; Mbalaviele G
Cells; 2019 Oct; 8(10):. PubMed ID: 31590342
[TBL] [Abstract][Full Text] [Related]
42. Small-Molecule Inhibitors of PARPs: From Tools for Investigating ADP-Ribosylation to Therapeutics.
Kirby IT; Cohen MS
Curr Top Microbiol Immunol; 2019; 420():211-231. PubMed ID: 30242511
[TBL] [Abstract][Full Text] [Related]
43. Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts.
Daugherty MD; Young JM; Kerns JA; Malik HS
PLoS Genet; 2014; 10(5):e1004403. PubMed ID: 24875882
[TBL] [Abstract][Full Text] [Related]
44. Combining Chemical Genetics with Proximity-Dependent Labeling Reveals Cellular Targets of Poly(ADP-ribose) Polymerase 14 (PARP14).
Carter-O'Connell I; Vermehren-Schmaedick A; Jin H; Morgan RK; David LL; Cohen MS
ACS Chem Biol; 2018 Oct; 13(10):2841-2848. PubMed ID: 30247868
[TBL] [Abstract][Full Text] [Related]
45. A Study into the ADP-Ribosylome of IFN-γ-Stimulated THP-1 Human Macrophage-like Cells Identifies ARTD8/PARP14 and ARTD9/PARP9 ADP-Ribosylation.
Higashi H; Maejima T; Lee LH; Yamazaki Y; Hottiger MO; Singh SA; Aikawa M
J Proteome Res; 2019 Apr; 18(4):1607-1622. PubMed ID: 30848916
[TBL] [Abstract][Full Text] [Related]
46. Beyond protein modification: the rise of non-canonical ADP-ribosylation.
Schuller M; Ahel I
Biochem J; 2022 Feb; 479(4):463-477. PubMed ID: 35175282
[TBL] [Abstract][Full Text] [Related]
47. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
[TBL] [Abstract][Full Text] [Related]
48. PARPs and the DNA damage response.
Sousa FG; Matuo R; Soares DG; Escargueil AE; Henriques JA; Larsen AK; Saffi J
Carcinogenesis; 2012 Aug; 33(8):1433-40. PubMed ID: 22431722
[TBL] [Abstract][Full Text] [Related]
49. Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation.
O'Sullivan J; Tedim Ferreira M; Gagné JP; Sharma AK; Hendzel MJ; Masson JY; Poirier GG
Nat Commun; 2019 Mar; 10(1):1182. PubMed ID: 30862789
[TBL] [Abstract][Full Text] [Related]
50. Players in ADP-ribosylation: Readers and Erasers.
Verheugd P; Bütepage M; Eckei L; Lüscher B
Curr Protein Pept Sci; 2016; 17(7):654-667. PubMed ID: 27090904
[TBL] [Abstract][Full Text] [Related]
51. Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes.
Wigle TJ; Church WD; Majer CR; Swinger KK; Aybar D; Schenkel LB; Vasbinder MM; Brendes A; Beck C; Prahm M; Wegener D; Chang P; Kuntz KW
SLAS Discov; 2020 Mar; 25(3):241-252. PubMed ID: 31855104
[TBL] [Abstract][Full Text] [Related]
52. Characterization of DNA ADP-ribosyltransferase activities of PARP2 and PARP3: new insights into DNA ADP-ribosylation.
Zarkovic G; Belousova EA; Talhaoui I; Saint-Pierre C; Kutuzov MM; Matkarimov BT; Biard D; Gasparutto D; Lavrik OI; Ishchenko AA
Nucleic Acids Res; 2018 Mar; 46(5):2417-2431. PubMed ID: 29361132
[TBL] [Abstract][Full Text] [Related]
53. The Promise of Proteomics for the Study of ADP-Ribosylation.
Daniels CM; Ong SE; Leung AK
Mol Cell; 2015 Jun; 58(6):911-24. PubMed ID: 26091340
[TBL] [Abstract][Full Text] [Related]
54. The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation.
Alhammad YMO; Fehr AR
Viruses; 2020 Mar; 12(4):. PubMed ID: 32244383
[TBL] [Abstract][Full Text] [Related]
55. Insights into the biogenesis, function, and regulation of ADP-ribosylation.
Cohen MS; Chang P
Nat Chem Biol; 2018 Feb; 14(3):236-243. PubMed ID: 29443986
[TBL] [Abstract][Full Text] [Related]
56. [Role of PARP and protein poly-ADP-ribosylation process in regulation of cell functions].
Drel' VR; Shymans'kyĭ IO; Sybirna NO; Velykyĭ MM
Ukr Biokhim Zh (1999); 2011; 83(6):5-34. PubMed ID: 22364016
[TBL] 
